UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Back to APGE Full portfolio

Position in APGE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,817,648

+$4,074,503 QoQ

Shares Held

66,433

+17.9% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 285 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 41% Shared 0% None 59%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. APGE ranks #42 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in APGE

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,817,648	66,433	+17.9%	Shares	Defined	2026-08-13
2026-03-31	$4,743,145	56,352	+13.1%	Shares	Defined	2026-05-13
2025-12-31	$3,759,280	49,805	+59.8%	Shares	Defined	2026-02-13
2025-09-30	$1,238,105	31,163	-43.4%	Shares	Defined	2025-11-14
2025-06-30	$2,391,342	55,062	+54.1%	Shares	Defined	2025-08-14
2025-03-31	$1,334,722	35,726	+10.7%	Shares	Defined	2025-05-19
2024-12-31	$1,461,422	32,261	+0.1%	Shares	Defined	2025-02-14
2024-09-30	$1,893,835	32,241	-6.3%	Shares	Defined	2024-11-14
2024-06-30	$1,353,756	34,403	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.